Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by amyloid-beta (Ab) plaques and tau neurofibrillary tangles. APPswe/PS1dE9 (APP/PS1) mice have been developed as an AD model and are characterized by plaque formation at 4-6 months of age. Here, we sought to better understand AD-related cognitive decline by characterizing various types of memory. In order to better understand how memory declines with AD, APP/PS1 mice were bred with ArcCreER T2 mice. In this line, neural ensembles activated during memory encoding can be indelibly tagged and directly compared with neural ensembles activated during memory retrieval (i.e., memory traces/engrams). We first administered a battery of tests examining depressive-and anxietylike behaviors, as well as spatial, social, and cognitive memory to APP/PS1 3 ArcCreER T2 3 channelrhodopsin (ChR2)-enhanced yellow fluorescent protein (EYFP) mice. Dentate gyrus (DG) neural ensembles were then optogenetically stimulated in these mice to improve memory impairment.
neurotoxic amyloid plaques, leading to neurodegeneration and dementia (Hardy and Allsop, 1991) . The strongest evidence for this comes from molecular genetic studies of amyloid precursor proteins (APPs) and presenilins 1 and 2 (PS1, PS2) in early onset familial AD, showing that all genetically linked AD mutations increase the propensity for Ab to aggregate in vitro (Selkoe, 2001) . Mice with both the APPswe and PS1dE9 mutant transgenes have previously been developed (Jankowsky et al., 2001) , with Ab deposition appearing as early as 4 months of age (Jankowsky et al., 2004 ). These mice model multiple aspects of AD; they have poor coordination using a rotarod (Volianskis, Køstner, Mølgaard, Hass, & Jensen, 2010) , contextual memory deficits (Gong et al., 2004; Kilgore et al., 2010) , and impaired spatial learning in the Morris water maze (Gong et al., 2004; Lalonde, Kim, Maxwell, & Fukuchi, 2005) . Although this mouse line has been commercially available for some time, a complete behavioral analysis has not yet been performed to uncover the extent of behavioral and memory deficits with AD progression.
Growing evidence points to a link between the immediate early gene (IEG) Arc/Arg3.1 and AD. Arc is predominantly expressed in cortical and hippocampal glutamatergic neurons and is required for long term potentiation (LTP) maintenance and memory consolidation (Guzowski et al., 2000; Lyford et al., 1995; Steward and Worley, 2001 ).
Rodent studies report decreased IEG expression in cortical and hippocampal regions with AD (Palop et al., 2005; Rudinskiy et al., 2012) . Wu et al. (2011) showed that Arc expression is required for the activitydependent Ab generation and for APP dysfunction. Furthermore, individuals with a novel Arc single nucleotide polymorphism reportedly have a reduced risk of AD (Landgren et al., 2012) . Since Arc expression has been directly tied to AD, here, we proposed to utilize Arc expression as proxy of neuronal activity in order to localize AD-related memory deficits.
We previously generated a murine line that can be used to tag individual memories. The ArcCreER T2 mice can have an indelible tag on neural ensembles activated during learning with EYFP, and these populations can then be compared with those activated during memory retrieval, as labeled using Arc or c-Fos protein (Denny, Burghardt, Schachter, Hen, & Drew, 2014) . This line is unique in that, unlike most existing tools (e.g., Reijmers, Perkins, Matsuo, & Mayford, 2007) , it allows for the permanent labeling of activated neural ensembles, thereby permitting long-term or age-related studies. Using the ArcCreER T2 mice, we previously demonstrated that neuronal ensembles in the dentate gyrus (DG) and CA3 hippocampal subregions are necessary for memory expression, and these memory traces are impacted by context, time, and adult hippocampal neurogenesis (Denny et al., 2014) .
Moreover, we have recently improved our protocols to tag neuronal ensembles by using superior pharmacological targeting windows, allowing for more specific studies (Cazzulino, Martinez, Tomm, & Denny, 2016) .
Here, we first administered an array of behavioral tests to the APP/PS1 3 ArcCreER T2 3 ChR2-EYFP mice in order to better understand how AD impacts behavior and memory as the disease develops.
We hypothesized that if any deficits exist, they would be evident in the oldest age group, as plaque number increases. We found substantial deficits in social, spatial, and cognitive memories with onset of plaque development, with the most extensive quantifiable changes being in contextual fear conditioning (CFC). CFC deficits were accompanied by normal levels of EYFP and Arc labeling in the DG but by decreased EYFP 1 /Arc 1 co-labeling, suggesting a decreased recruitment of the original CFC memory trace. These data suggest that AD cognitive impairments result from weakened memory traces in that the memory is originally stored correctly in the brain, but cannot be properly accessed. The CFC memory deficits were rescued via optogenetic activation of the previously encoded DG-dependent CFC memory trace.
These findings support the hypothesis that targeting or stimulating the DG may be a successful method to treat memory loss, particularly cognitive or contextual memory loss, in AD.
(1) mice (Denny et al., 2014) (predominantly 129S6/SvEv) were bred with ROSA26-CAG-stop flox -ChR2(H134R)-EYFP (Ai32) (Madisen et al., 2012) (predominantly 129S6/SvEv but mixed with C57BL/6).
Triple transgenic lines were then generated in which male ArcCreER T2
(1) x ChR2-EYFP homozygous (f/f) mice were bred with a mouse model of AD, female B6.Cg-Tg(APPswe; PSEN1dE9) 85Dbo/ Mmjax (APP/PS1) mice (034832-JAX, MMRRC) (Jankowsky et al., 2004) . This APP/PS1 line (on a C57BL/6 background) had a relatively high incidence of seizures (Minkeviciene et al., 2009) . By crossing these mice with ArcCreER T2 mice, which are primarily bred on a 129S6/SvEv background, we were able to significantly reduce seizure frequency (data not shown). Male mice were used in all experiments. The Ctrl mice were: APP/PS1(-) 3 ArcCreER
T2
(1) or (-) 3 ChR2-EYFP(1/f). The AD mice were: APP/PS1(1) 3 ArcCreER
(1) or (-) 3 ChR2-EYFP(1/f).
| Genotyping
The Cre and ChR2 genotyping was performed as previously described (Denny et al., 2014) . The APP and PSEN genotyping was performed as described on the Jackson Laboratory website. All genotyping was performed separately.
| Standard housing and dark housing
Mice were housed 4-5 per cage in a 12-hr (06:00-18:00) light-dark colony room maintained at 22 8C. Food and water were provided ad libitum. Behavioral testing was performed during the light phase. Each cohort was tested at the specific age to which it was assigned and mice were not tested at multiple ages.
Dark housing procedures occurred as previously described (Denny et al., 2014) . Briefly, mice were dark housed the night before and then for 3 days following the 4-hydroxytamoxifen (4-OHT) 4-OHT injection. 
| Behavioral tests
Behavioral assays were performed on 2-, 4-, and 6-month-old mice.
These assays were administered over 10 days. Please see Supporting
Information Table S1 for the behavioral assays, as well as Supporting
Information for additional behavioral tests and modified versions of the tests.
| Contextual fear conditioning
The one-and three-shock CFC protocols were administered as previously described in Drew, Denny, and Hen (2010) and Denny et al. (2012) . For the one-shock CFC protocol, mice were placed into the conditioning chamber, received 1 shock at 180 s (2 s, 0.75 mA), and were removed 15 s following the shock. For the three-shock CFC procedure, mice were placed in the conditioning chamber, received 3 shocks 180, 240, and 300 s later (2 s, 0.75 mA), and were removed 15 s following the last shock.
| Drugs
Recombination was induced with 4-OHT (Sigma, St Louis, MO). 4-OHT was dissolved by sonication in 10% EtOH/90% corn oil at a concentration of 10 mg/ml; each mouse was injected intraperitoneally (i.p.) with 200 ml (2 mg) (Cazzulino et al., 2016 ).
Mice were given an i.p. injection of Methoxy-X04 (5 mg/kg; Tocris Bioscience, Minneapolis, MN) 24 h prior to sacrifice to label plaques (Meyer-Luehmann et al., 2008) . This procedure was adapted from Rudinskiy et al. (2012) .
| Immunohistochemistry
Brains were processed as previously described (Cazzulino et al., 2016; Denny et al., 2014) .
| Cell quantification
An investigator blind to treatment used a Zeiss Axioplan-2 upright microscope to count immunoreactive cells bilaterally in the DG throughout the entire rostrocaudal axis as previously described in Cazzulino et al. (2016) and Denny et al. (2014) .
| Confocal microscopy
Fluorescent confocal micrographs were captured with a Leica TCS SP8 MP microscope as previously described in Cazzulino et al. (2016) . To obtain the percent of reactivated cells, the total numbers of Arc 
| Statistical analysis
All data were analyzed using StatView (v. 5.0) software (SAS Institute).
Data were analyzed using ANOVA, with repeated measures where appropriate. For each behavioral test, a priori planned comparisons (i.e., planned orthogonal contrasts) were performed for each age group in order to highlight genotype comparisons at each age and to test the hypothesis that behavioral deficits worsen with plaque development.
For the regression analyses, the average CFC freezing versus either Table S2 .
| R ESU L TS
3.1 | AD disease progression as evidenced by amyloid deposits increases from 2 to 6 months of age
The APP/PS1 model (Jankowsky et al., 2014) was utilized and bred with the ArcCreER T2 (Denny et al., 2014) Red and Chrysamine-G (Klunk et al., 2002) , 24 hr before sacrifice.
Methoxy-X04 deposits were observed in both 4-and 6-month-old AD mice, but not in 2-year-old mice ( Figure 1c ). The number and size of Methoxy-X04 deposits also increased with age, which is consistent with previous studies (Garcia-Alloza et al., 2006; Volianskis et al., 2010) .
| Depressive-and anxiety-like behavior is not altered by AD
The forced swim test (FST) was utilized to determine if AD impacts depressive-like behavior. On Day 1, all mice had comparable immobility iors at 2-to 6-months of age in the APP/PS1 mice.
| Novelty detection is impaired by aging, but not AD
Novelty detection was tested by first administering a 2-trial novel object recognition (NOR) paradigm (Figure 3a -c) as we previously described (Oury et al., 2013) . Ctrl and AD mice failed to detect the novel object (Figure 3c ), suggesting that in this murine line, more time is needed to sufficiently encode the initial two objects.
Next, a five-trial NOR paradigm was administered to determine if increased exposures would allow mice to sufficiently encode the two objects (Denny et al., 2012) (Figure 3d -m). In this procedure mice were habituated to two objects for four exposures, followed by a single exposure with one familiar (constant) object and one novel object. All mice had similar levels of activity across exposures (Figure 3e-g ). There was a significant effect of Age, but not of Genotype on object investigation during habituation (Figure 3h-j) . During the replacement trial, both Ctrl and AD mice detected the novel object, as evidenced by increased novel object exploration when compared with that of the constant object . These data indicate that novelty detection is not severely impacted by AD.
| Spatial working memory and social recognition is impaired by AD
To test spatial memory, an unbaited Y-maze was utilized (Figure 4a ). At 2 months of age, both the Ctrl and AD mice explored the novel arm significantly more than the constant arm during the test trial ( Figure   4b ). However, at 4 months of age, AD mice showed similar levels of exploration of both arms, while the Ctrl mice explored the novel arm significantly more than the constant arm (Figure 4c ). At 6 months of age, Ctrl and AD mice explored both arms similarly (Figure 4d ).
To ensure that mice were using contextual cues outside of the Y-maze, in a separate experiment, the Y-maze was rotated 180 8 between training and test trials (Supporting Information Figure S1a ). Ctrl mice showed equal exploration of both arms (Supporting Information Figure S1b ), suggesting that outside contextual cues do influence the arm distinction. Moreover, these data suggest that this version of the task is too complex and more training trials would be necessary for enhanced performance.
Next, to test social investigation and to ensure that Ctrl and AD mice able of detecting social stimuli, a 1-trial social investigation test was administered using juvenile male mice (Supporting Information Fig- ure S1c). The time exploring an empty cup or a cup containing a novel male mouse was measured. Ctrl and AD mice were capable of detecting and investigating a novel male mouse, as evidenced by increased investigation of the mouse (Supporting Information Figure S1d ).
We next tested social memory of ovariectomized female conspecifics with a social recognition (SR) paradigm for Ctrl and AD mice (Figure 4e) . During Trial 1, there was an effect of Age, but not of Genotype, on the amount of exploration of the novel mouse when compared with that of the empty cup (Figure 4f-h ). During the second trial, at 2 months of age, both Ctrl and AD mice explored the novel mouse more than the familiar mouse ( Figure 4i ). However, at 4 months, Ctrl but not AD mice explored the novel mouse more than the familiar mouse (Figure 4j ). At 6 months of age, both Ctrl and AD mice investigated the novel and familiar mouse equally (Figure 4k ). These data indicate that all mice show age related deficits in SR, but these are exacerbated and occur earlier in AD mice.
| Contextual fear memory is impaired by AD and this correlated with impaired DG memory traces
Last, in order to test long-term contextual fear memory, either one-or three-shock CFC procedures were administered to Ctrl and AD mice (Figure 5a ). To create the indelible label of memory encoding, 4-OHT was injected 5 hr prior to CFC (Figure 5b ). For the 1-shock CFC procedure, at 2 months of age, both Ctrl and AD mice had comparable, albeit low, levels of freezing during the context test which was administered 5 days after the 1-shock procedure. However, at 4 and 6 months, while freezing increased in general over that of 2-month-old mice, AD mice exhibited lower levels of freezing when compared with Ctrl mice (Figure 5c ). Although this weak procedure produces variable freezing across age, memory retrieval using a 1-shock CFC protocol is impaired in AD mice at 4 and 6 months of age.
After the context test, the mice were sacrificed, and immunohistochemistry was performed to quantify EYFP (memory encoding), Arc (memory expression), and EYFP 1 /Arc 1 co-labeling (memory traces) in the DG (Figure 5d-f) . For 1-shock CFC, Age but not Genotype impacted the number of EYFP 1 cells; 2-month-old mice had less EYFP 1 DG cells when compared with 4-and 6-month-old groups ( Figure 5D ). Neither
Genotype nor Age impacted the number of Arc 1 cells (Figure 5e ).
However, at 6 months of age, but not 2 or 4 months of age, AD mice had significantly less co-labeled DG cells than did Ctrl mice ( Figure   5f ), suggesting that the originally encoded memory trace was not being recalled properly and that the behavioral deficit was paralleled In exposure 2, Ctrl and AD mice had similar levels of exploration, as measured by grid crossings. (c) Ctrl and AD mice had similar levels of investigation of the two objects, with both groups showing no preference for the novel object, suggesting that this paradigm is not sufficient for testing long-term NOR (n 5 3-4 male mice per group). (d) Experimental design. (e-g) Ctrl and AD mice had similar levels of exploration, as measured by grid crossings, at all ages measured. (h-j) Ctrl and AD mice had similar levels of investigation of the two objects at all ages measured. (k-m) Ctrl and AD mice investigated the novel object significantly more than the constant object at 2, 4, and 6 months of age (n 5 6-13 male mice per group). Error bars represent 6 SEM. *p < .05; **p < .01; ***p < .001. min, minutes; NOR, novel object recognition; Ctrl, control; AD, Alzheimer's disease; s, seconds; No., number by impaired DG memory traces. Moreover, because 2-month-old mice displayed similar EYFP and Arc DG levels to 4-month-old mice and 6-month-old Ctrl mice, this suggests that these cells do not represent behavioral output but rather contextual memory.
For three-shock CFC, there was an overall effect of Genotype on freezing behavior (Figure 5g ). At 2 and 4 months, Ctrl and AD mice showed comparable levels of freezing during the context test, which was administered 5 days after the initial three-shock procedure.
However, at 6 months, AD mice showed a robust decrease in freezing in the aversive context when compared with Ctrl mice ( Figure 5G ).
Although not statistically significant, 6-month-old Ctrl mice froze slightly more than did the two younger age groups, contributing to the striking difference observed between genotype at this age. These data indicate that CFC memory retrieval using a stronger shock protocol is simultaneously most impaired in AD mice and strongest in Ctrl mice at 6 months of age. (k) At 6 months, both groups of mice explore the novel and familiar mice comparably during trial 2 (n 5 6-13 male mice per group). Error bars represent 6 SEM. *p < .05; **p < .01; ***p < .001.Ctrl, Control; AD, Alzheimer's disease; s, seconds; ITI, intertrial interval Following the same procedure as for one-shock CFC, mice were sacrificed after the context test, and immunohistochemistry was performed to quantify EYFP, Arc, and co-labeling in the DG (Figure 5h-j) .
For three-shock CFC, both Ctrl and AD mice had comparable expression of DG EYFP 1 and Arc 1 cells across all ages (Figure 5h-i) .
However, at 6 months, AD mice had significantly less co-labeling in the DG when compared with Ctrl mice (Figure 5j ). These data suggest that CFC becomes impaired with age but that these deficits are more profound in AD mice. This is paralleled by altered DG memory traces at more advanced stages of plaque development.
To address the varied freezing across age and to determine which factors contributed to fear expression, simple regression analyses with all one-and three-shock CFC data were performed. For 6-month-old mice, the number of EYFP 1 and co-labeled cells in the DG, but not Table S2 ). This suggests that, in the oldest group, both the cells representing the originally encoded memory and those representing the memory trace best predict freezing behavior.
3.6 | Optogenetic stimulation of a CFC DG memory trace improves memory retrieval in 6-month-old mice
Given the robust behavioral and IEG differences observed between 6-month-old AD and Ctrl mice, we hypothesized that impaired threeshock CFC is due to weakened contextual memory retrieval in the DG mice (n 5 6-13 male mice per group). Error bars represent 6 SEM. *p < .05; **p < .01; ***p < .001. 4-OHT, 4-hydroxytamoxifen; Sac, sacrifice; CFC contextual fear conditioning; Ctrl, control; AD, Alzheimer's disease; %, percent; EYFP, enhanced yellow fluorescent protein; DG, dentate gyrus.
with AD and that optogenetic stimulation of the neural ensemble representing this encoded memory would improve memory retrieval. Sixmonth-old APP/PS1 3 ArcCreER T2 3 ChR2-EYFP mice were implanted with fiber optics directly above the DG (Figure 6a ). Mice were injected with 4-OHT and, 5 hr later, exposed to context A and given three shocks ( Figure 6B ). Mice were then exposed to context A without shocks 5 days after the initial three-shock CFC training, first with optogenetic stimulation for 3 min (2-3 mW, 10 Hz stimulation at 20 ms pulses) and then with no optogenetic stimulation for 3 min.
Optogenetically stimulating the DG in APP/PS1 3 ArcCreER | 1119 AD) mice did not impact freezing behavior, as AD mice froze significantly less than Ctrl mice ( Figure 6C ). However, optogenetically stimulating the DG in APP/PS1 3 ArcCreER
T2
(1) (Cre1 AD) mice increased freezing behavior throughout the session; AD and Ctrl mice froze at comparable levels (Figure 6d-e) .
The following day, during a context test without light stimulation, Cre-AD mice froze significantly less than Cre-Ctrl mice (Figure 6f ).
Moreover, Cre1 AD mice also froze significantly less than Cre1 Ctrl mice (Figure 6g-h ). These data suggest that the improvements seen during the previous optogenetic stimulation are not long-lasting and that increased optogenetic stimulation is needed if long-lasting cognitive improvements are possible.
In order to determine if the timing of laser presentation impacts behavior and to more definitively attribute increased freezing to laser stimulation, mice received laser OFF and then laser ON periods in context A (Figure 6b ). Cre-AD mice froze significantly less than Cre-Ctrl mice during the laser OFF and laser ON periods (Figure 6i ). Cre1 AD mice froze significantly less than Cre1 Ctrl mice during the laser OFF period (Figure 6j ). However, during the laser ON period, Cre1 AD mice froze comparably to Cre1 Ctrl mice, again suggesting that optogenetic stimulation is capable of rescuing the memory deficit in AD mice at any portion of the context test (Figure 6j,k) . These data suggest that optogenetic stimulation of an aversive contextual memory trace rescues the three-shock CFC memory impairment in AD mice, as evidenced by increased freezing in the shock context.
Last, mice were sacrificed after 10 min of laser stimulation, and immunohistochemistry was performed for Cre1 mice as previously described ( Figure 5 ). Both Cre1 Ctrl and AD mice had similar levels of DG EYFP and Arc expression (Figure 6l-n) . However, stimulation increased overall DG co-labeling in Cre1 AD mice, significantly higher than in impaired AD mice without stimulation (Supporting Information   Table S2 ). This increased DG co-labeling reflects the behavioral improvements for Cre1 AD mice during optogenetic stimulation of the appropriate CFC memory trace. Moreover, for all Cre1 mice, irrespective of Genotype, co-labeling was significantly increased in DG sections directly under the ferrule (i.e., DG sections directly simulated by the laser) compared with those past the ferrule (i.e., DG sections not directly stimulated by the laser) (Figure 6o ). Therefore, these data show that optogenetic stimulation of DG engrams improves memory retrieval in AD mice by increasing the reactivation of neural ensembles which were active during memory encoding.
| D I SCUSSION
AD has become a devastating societal and health problem among the elderly. In this study, we aimed to first characterize the time course of changes in multiple behavioral domains in an AD mouse model. Some behaviors were unaffected by plaque development, namely anxiety-like behaviors and novelty detection. However, we found that social, spatial, and cognitive memories were severely impaired with plaque progression. These data are in accord with other studies using similar AD murine lines. For example, spatial memory deficits using the water maze (Cao, Lu, Lewis, & Ling, 2007; Lalonde et al., 2005) , as well as SR deficits (Hsaio, Hung, Hung, & Gean, 2014) , have been found in APP/ PS1 mice. Most importantly, here, we report that one of the most robust and measurable deficits were in cognitive fear memory as assessed by CFC. This is consistent with human literature on ADrelated memory dysfunction, especially as AD progresses into later stages (e.g., Koedam et al., 2010) .
After both one-and three-shock CFC, DG EYFP and Arc expression were comparable across all groups despite behavioral memory deficits occurring at 6 months of age. Since we utilized a murine line that allows for indelible labeling of memory traces, we were able to compare neuronal populations active during memory encoding and retrieval. EYFP degraded, but is difficult to access for memory retrieval or behavioral expression when AD is present. Because we were able to improve fear memory deficits in these studies, in the future it may be possible optogenetically stimulate neural ensembles representing SR or spatial memories to also improve these impairments in these triple transgenic mice.
Two recent studies are particularly relevant to interpreting our data.
First, a recent study similarly used optogenetics to reactivate fear memory traces in AD mice (Roy et al., 2016) . In this study, the authors were able to also temporarily increase freezing during light stimulation; however, the stimulation was never performed in the CFC training context but in a completely novel context. It is unclear from the procedure whether they were activating the complete CFC engram or cells representing behavioral output (i.e., freezing). Here, we optogenetically stimulated cells labeled during CFC training in the same aversive context.
With a procedure utilizing the same aversive context for both CFC training and memory recall, we provide a cleaner and more accurate comparison of cells active during encoding versus retrieval, which allows for a more meaningful interpretation of co-labeled cells. Moreover, we have shown that we can improve fear memory to unimpaired Ctrl levels within the relevant context and not an alternate one; testing in an alternate context could be inappropriate in practice or clinical instances. Second, a recent study also showed that optogenetically driving fast-spiking Parvalbumin 1 hippocampal interneurons at gamma, but not other frequencies reduced the levels of Ab (Iaccarino et al., 2016) . These data suggest that non-invasively targeting brain rhythms may improve memory retrieval by decreasing the AD-associated pathology. Altogether, both studies suggest that optogenetic modulation during AD progression results in improved memory and also highlights the hippocampus as a node of influence for improving long-term memory retrieval.
In summary, these data represent an in-depth behavioral and IEG profiling of the APP/PS1 murine model commonly used to study AD.
We have identified distinct memory deficits that occur with AD progression. We believe that each of these behaviors (cognitive, spatial, and social) is mediated by distinct memory traces that will require distinct targeting procedures to potentially improve deficits. In the case of one-and three-shock CFC, we have localized memory trace impairments in the DG and optogenetically targeted the cells used to originally encode the CFC memory. This context-specific memory trace activation rescued memory retrieval, as indicated by the enhanced degree of IEG expression overlap. Overall, these findings propose that the DG is a prime target for treating AD-related cognitive decline.
EDITOR STATEMENT
This data are both novel and of high impact for several reasons. Although the APP/PS1 mice are commonly used to study AD, there is yet to be published a complete behavioral analysis. With the APP/PS1 3 ArcCreER T2 3 ChR2-EYFP mice, we are able to indelibly tag an individual memory, and therefore, localize individual memories during the course of AD development. Our data suggest that optogenetically activating a previously learned DG memory trace (e.g., engram) can rescue memory loss during AD development. Moreover, our data point to DG manipulation as a potential target to treat memory loss commonly seen in AD.
These data will be invaluable for such experiments and for the AD community.
